Extraction Kits Market Outlook (2023 to 2033)

The global demand for extraction kits is expected to increase at 7.1% CAGR over the forecast period. The extraction kits market size is estimated to reach a valuation of USD 1,293.4 million by 2023. According to the study, DNA extraction kit products held a substantial share of 49.88% in 2022 in the global market.

Salient Factors Catalyzing the Market Growth Include:

  • Surging investments in research and development activities in diverse areas like infectious diseases and molecular diagnostics.
  • Key participants are focusing on releasing new products in the market to meet the evolving end user’s demand.
  • Soaring burden of cancer patients across the world is underscoring the necessity of extraction kits.
  • Key manufacturers are concentrating on automating the extraction technology, thus contributing toward product upgradation.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Opportunities for Extraction Kits Manufacturers?

An increasing number of research and development activities to develop vaccines to combat the diseases is expected to boost the market. Hence, key players are investing extensively to gain a competitive edge in the industry.

Other initiatives, such as the EMBO, and Young Investigator Program aids in the establishment of laboratories by life scientists. Under this initiative, the young researchers are expected to receive funding for four years. This is going to help them to establish their networking and training, enhancing their research development.

All research initiatives are projected to help the key players in the market to expand their footprints in emerging economies. Such situations are expected to help create attractive opportunities for local players to strengthen their position and increase their market share over the forecast period.

Key Factors Restraining the Extraction Kits Demand

  • Handling the extraction kits for the isolation of nucleic acids in forensic studies requires expert personnel. Currently, several countries do not have sufficiently trained personnel who can assist and expedite this process.
  • Stringent regulatory dynamics by regulatory authorities, such as the USA Food and Drug Administration (FDA), USDA (USA Department of Agriculture), and EPA (Environmental Protection Act) may hinder the market expansion over the forecast period.
Data Points Market Insights
Extraction Kits Industry Value 2022 USD 1,218.4 million
Extraction Kits Market Value 2023 USD 1,293.4 million
Extraction Kits Market Value 2033 USD 2,556.6 million
Extraction Kits Industry CAGR 2023 to 2033 7.1%
Market Share of Top 5 Countries 56.5%

Sales Analysis of Extraction Kits Market from 2018 to 2022 Vs Demand Outlook for 2023 to 2033

According to Future Market Insights (FMI), the overall sales of extraction kits expanded at a CAGR of 7.4% between 2018 and 2022. However, the demand in the extraction kits industry is expected to increase at a CAGR of 7.1%, surpassing USD 2,556.6 million by the end of 2033.

The global extraction kits market held around 5.0% of the global genome sequencing market, which was valued at nearly USD 23 billion in the year 2021.

Market expansion is underpinned by growing innovation in molecular diagnostic techniques, resulting in the detection of numerous diseases. Integration of automation in these extraction systems is projected to simplify and improve the yield of nucleic acid extraction.

For instance, Indian start-up 30M Genomics has developed a new extraction kit called AmpReady for extracting DNA from biological samples in five seconds without requiring any equipment. These kits offer accuracy and higher efficiency in analysis.

With a slew of advancements in automation for nucleic acid extraction, the market is projected to witness impressive growth over the coming years.

Rising investment by government bodies and other organizations for research and development activities in molecular diagnostics is likely to fuel the market. Increased funding for life science research and investments in molecular diagnostics is projected to fuel market growth.

According to UNESCO’s data, Germany spent about USD 4 billion in 2021 to promote and boost research and development activities in the country. In China, the National Bureau of Statistics stated that China spent almost USD 440.0 billion on research and development in 2021.

As per the study, there was a 40% rise in spending as compared to 2020. As research and development funding activities are increasing across the globe, the extraction kits industry is poised to expand at a steady rate.

Based on product, DNA extraction kits were the dominant market segment in the global market in 2022, which contributed 49.88% of the revenue share. The global extraction kits market is expected to be valued at USD 2,556.6 million by the end of 2033, registering a CAGR of 7.1% in the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Geographical Forecast of Extraction Kits Market

North America to be Crowned as the Leading Market in the Extraction Kits Industry

Region North America
Market Share % 2022 33.4%
Market Size (USD million) by 2023 USD 431.99 million
Market Size (USD million) by End of Forecast Period (2033) USD 853.90 million

North America region held a market share of 33.4% in 2022. The market growth has been underpinned by several research and development activities. In addition to this, industry players are consistently updating their product portfolios, which is assessed to positively influence market trajectory. Other factors stimulating regional growth include:

  • Increasing investments by private sectors and government bodies to further research and development activities.
  • High frequency of chronic diseases such as cancer in the region. Breast cancer has been commonly detected in the United States as per historical estimates.

Europe to Observe Supportive Government Initiatives in Future

Region Europe
Market Share % 2022 28.7%
Market Size (USD million) by 2023 USD 371.2 million
Market Size (USD million) by End of Forecast Period (2033) USD 733.74 million

In 2022, Europe acquired a 28.7% market share in the global landscape. In the same year, the region gained USD 371.2 million, and by 2033, the market is projected to gain USD 733.74 million.

The large contribution of Europe in the global sphere is due to the accelerating patient population and beneficial government initiatives. Take for example, in 2020, Merck invested USD 21.09 million to create a life sciences lab in Switzerland, Europe.

This is projected to expedite and encourage research and development activities for the company, in addition to quality control and analytical production.

Country-wise Insights: FMI Shares Micro-level Statistics and Insights into the Market

Technological Advances for Automation in DNA Extraction Kits to Boost the United States Market

Country The United States
Market Share % 2022 31%
Market Size (USD million) by 2023 USD 400.95 million
Market Size (USD million) by End of Forecast Period (2033) USD 792.54 million

According to Future Market Insights, the United States is expected to dominate North America, with a total market share of 92.8% in 2022. The country is projected to continue to exhibit high growth through 2023 and beyond.

In the global landscape, the United States’ share in the market stood maximum at 31% in 2022. In 2023, the market is assessed to amass a total of USD 400.95 million. Similarly, by the forecast period’s end, the market is estimated to be valued at a maximum of USD 792.54 million.

Technological advancements in the automation of DNA & RNA extraction across the United States is projected to drive product demand. For instance, Thermo Fischer Scientific launched the Thermo Scientific KingFisher Apex Purification System in April 2021.

Manufacturers in Germany Investing Effectively in Research and Development to Create Advanced RNA Extraction Kits

Country Germany
Market Share % 2022 7.3%
Market Size (USD million) by 2023 USD 94.41 million
Market Size (USD million) by End of Forecast Period (2033) USD 186.63 million

Germany is set to exhibit growth at a CAGR of 8.3% in Europe’s extraction kits market during the forecast period. Germany’s market captured 7.3% of the global market in 2022. By the end of the assessment period, the market is projected to be valued at a sum of USD 186.63 million.

Increasing investment in research and development in Germany is uplifting the regional market status. Also, the development of new technologies for the fast detection of clinically important compounds is projected to facilitate market expansion.

China Expanding on the Development of RNA Extraction Kits for RNA Purification to Fortify its Market Position

Country China
Market CAGR % through till 2033 9.8%

China is projected to expand at a CAGR rate of 9.8% during the forecast period, anticipating Future Market Insights (FMI). China is expected to spearhead the growth in East Asia due to technological advancement in the healthcare sector.

Key players in the country are working toward developing sophisticated automated systems for nucleic acid extraction. Consequently, augmenting the product’s demand in the market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

DNA Extraction Kits to Account for Nearly Half the Sales in Extraction Kits Market

Segment DNA Extraction Kits
Market Share (2022) 49.88%
Market Size (2023) USD 645.14 million
Market Size (2033) USD 1,275.23 million

The DNA extraction kits contributed about 49.88% of the market share in 2022 and are expected to register a CAGR of 7.4% in the forecast period. The availability of a wide range of robust kits and ease of application in various molecular biology applications for the detection of nucleic acids in cancerous tissues is projected to aid segment growth.

Which is the Chief Application in Extraction Kits Market?

Nearly 2 out of 5 Extraction Kits Sales Come from Disease Diagnosis

Segment Disease Diagnosis
Market Share (2022) 37.08%
Market Size (2023) USD 479.59 million
Market Size (2033) USD 947.98 million

In terms of application, the disease diagnosis segment is expected to hold a 37.08% share in revenue, exhibiting growth at 7.8% CAGR in the forecast period. The increasing prevalence of chronic diseases, genetic disorders, and cancer has led to an increase in the use of DNA & RNA extraction kits. This is projected to contribute to the market expansion in the forecast period.

Why is the Demand for Extraction Kits Increasing in Diagnostic Laboratories?

Burgeoning Need for Nucleic Acid Extraction Kits in Diagnostic Laboratories to Propel the Sales

Based on end users, the diagnostic laboratories segment held a market share of more than 29.9% in 2022 and is poised to expand at a CAGR of 7.9% over the upcoming decade.

Demand for extraction kits in diagnostic laboratories is increasing due to the high adoption of nucleic acid extraction kits for identifying and characterizing microbes. These microbes are the prime cause of certain chronic ailments.

How can Manufacturers Scale their Business?

  • Leading extraction kit manufacturers are focusing on collaborations and new product launches to gain high revenue. This also helps to expand their sales footprint in emerging countries.
  • Low awareness surrounding these kits in underdeveloped regions offer significant growth opportunity to manufacturers. Vendors can proliferate their operations in new geographies to gain access to many end users.
  • Circulation of investment pockets in developed regions like Europe and North America to help manufacturers prepare progressive extraction kits is also expected to fuel business growth.
  • Creation of user-convenient and accurate extraction kits is gaining high traction in the market. Producers can focus on their manufacturing capacities to develop products aligned with consumers’ requirements.
  • Continuous deployment of general yet effective strategies like mergers, acquisitions, partnerships, and collaborations.

Key Players in the Extraction Kits Industry

  • Bio Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bioneer Corporation
  • PerkinElmer Inc.
  • LGC Biosearch Technologies
  • Qiagen
  • General Biosystems
  • Takara Bio Inc.
  • Roche Life Science
  • GeneReach Biotechnology Corporation.
  • Merck Millipore
  • BioFire Defense LLC
  • Akonni Biosystems, Inc
  • Primerdesign Ltd.

Key Developments in the Extraction Kits Market:

  • In July 2021, Bio-Rad Laboratories, Inc. announced its collaboration with Seegene, Inc. which is a provider of multiplex molecular diagnostics. The collaboration was done for the clinical development and commercialization of infectious disease molecular diagnostic products.
  • In March 2021, Promega Corporation launched XpressAmp™ Direct Amplification Reagents that facilitate RNA extraction-free sample preparation for laboratory testing for COVID-19.
  • In March 2021, Agilent Technologies Inc. launched a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. The product is CE-IVD marked under the European Union in-Vitro Diagnostic Directive 98/79/EC.
  • In August 2021, Shanghai Promega Biological Products Co., Ltd. and Shanghai Henlius Biotech, Inc. collaborated to develop and commercialize a microsatellite instability (MSI) companion diagnostic IVD kit to identify cancer patients.

Scope of Extraction Kits Market Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis USD million for Value
Key Regions Covered North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa
Key Countries Covered The United States, Canada, Brazil, Mexico, Argentina, Germany, the United Kingdom, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, North Africa, GCC Countries, Türkiye, and South Africa
Key Market Segments Covered Product, Application, End User, and Region
Key Companies Profiled Bio Rad Laboratories Inc.; Thermo Fisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation.; Merck Millipore; BioFire Defense LLC; Akonni Biosystems, Inc; Primerdesign Ltd.
Pricing Available upon Request

Key Market Segments Covered in Extraction Kits Industry Research

By Product:

  • DNA Extraction Kits
    • Sequence-specific DNA
    • Cell-free DNA (cfDNA)
    • Tissue DNA Extraction Kits
  • RNA extraction Kits
    • Total RNA
    • Purified RNAs
    • Viral RNA
    • Sequence-specific RNA
  • Total nucleic acid (RNA + DNA)

By Application:

  • Disease Diagnosis
  • Drug Discovery
  • Cancer Research
  • cDNA Library
  • Others

By End User:

  • Hospitals
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical Research Organizations
  • Diagnostic Laboratories
  • Forensic Labs

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Current Extraction Kits Market Valuation?

The market is estimated to secure a valuation of USD 1,293.4 million in 2023.

How Big will the Market by 2033?

The market is estimated to reach USD 2,556.6 million by 2033.

What is the Growth Potential of the Market?

Through 2033, the market is anticipated to expand at a 7.1% CAGR.

What Boosts the Growth Potential of the Market?

Enhancing government financing for the advancement of extraction technologies to establish new growth potential.

What is the Market Share of the United States?

The United States has a substantial market share at 31%.

Which Product Segment to Grab a Significant Share in the Market?

The DNA extraction kits accounted for about 49.88% of the market share.

Which Application Is Anticipated to Gain Momentum in the Market?

The disease diagnosis category is set to rise at a 7.8% CAGR.

Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
  • 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
    • 5.1. DNA Extraction Kits
      • 5.1.1. Sequence-specific DNA
      • 5.1.2. Cell-free DNA (cfDNA)
      • 5.1.3. Tissue DNA Extraction Kits
    • 5.2. RNA Extraction Kits
      • 5.2.1. Total RNA
      • 5.2.2. Purified RNAs
      • 5.2.3. Viral RNA
      • 5.2.4. Sequence-specific RNA
    • 5.3. Total nucleic acid (RNA + DNA)
  • 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
    • 6.1. Disease Diagnosis
    • 6.2. Drug Discovery
    • 6.3. Cancer Research
    • 6.4. cDNA Library
    • 6.5. Others
  • 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
    • 7.1. Hospitals
    • 7.2. Academic and Research Institutions
    • 7.3. Pharmaceutical and Biotechnology Companies
    • 7.4. Clinical Research Organisations
    • 7.5. Diagnostic Laboratories
    • 7.6. Forensic Labs
  • 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    • 8.1. North America
    • 8.2. Latin America
    • 8.3. Europe
    • 8.4. Asia Pacific
    • 8.5. MEA
  • 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
  • 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
  • 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
  • 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
  • 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
  • 14. Key Countries Market Analysis
  • 15. Market Structure Analysis
  • 16. Competition Analysis
    • 16.1. Bio Rad Laboratories Inc.
    • 16.2. Thermo Fisher Scientific
    • 16.3. Promega Corporation
    • 16.4. Agilent Technologies
    • 16.5. Bioneer Corporation
    • 16.6. PerkinElmer Inc.
    • 16.7. LGC Biosearch Technologies
    • 16.8. Qiagen
    • 16.9. General Biosystems
    • 16.10. Takara Bio Inc.
    • 16.11. Roche Life Science
    • 16.12. GeneReach Biotechnology Corporation.
    • 16.13. Merck Millipore
    • 16.14. BioFire Defense LLC
    • 16.15. Akonni Biosystems, Inc.
    • 16.16. Primerdesign Ltd.
  • 17. Assumptions & Acronyms Used
  • 18. Research Methodology
Recommendations

Healthcare

DNA/RNA Extraction Market

June 2023

REP-GB-10543

250 pages

Healthcare

Respiratory Pathogen Testing Kits Market

March 2023

REP-GB-10542

345 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Extraction Kits Market

Schedule a Call